Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
49.41 USD | -0.52% |
|
+9.13% | -33.13% |
06-27 | Scotiabank Initiates Exact Sciences at Sector Outperform With $70 Price Target | MT |
06-26 | BTIG Lowers Price Target on Exact Sciences to $70 From $80, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.13% | 9.17B | |
+19.33% | 4.14B | |
+11.62% | 2.63B | |
-7.63% | 1.95B | |
-26.46% | 1.85B | |
+37.94% | 1.22B | |
+49.58% | 969M | |
-9.17% | 694M | |
-19.58% | 235M | |
-11.97% | 168M |
- Stock Market
- Equities
- EXAS Stock
- News Exact Sciences Corporation
- Transcript : Exact Sciences Corporation, Mayo Clinic - Special Call